Terms: = Leukemia AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Diagnosis
17 results:
1. In silico comprehensive analysis of coding and non-coding SNPs in human mTOR protein.
Yasmin T
PLoS One; 2022; 17(7):e0270919. PubMed ID: 35788771
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies.
Filipiuk A; Kozakiewicz A; Kośmider K; Lejman M; Zawitkowska J
Ann Agric Environ Med; 2022 Jun; 29(2):207-214. PubMed ID: 35767752
[TBL] [Abstract] [Full Text] [Related]
3. Metabolomics of neonatal blood spots reveal distinct phenotypes of pediatric acute lymphoblastic leukemia and potential effects of early-life nutrition.
Petrick LM; Schiffman C; Edmands WMB; Yano Y; Perttula K; Whitehead T; Metayer C; Wheelock CE; Arora M; Grigoryan H; Carlsson H; Dudoit S; Rappaport SM
Cancer Lett; 2019 Jun; 452():71-78. PubMed ID: 30904619
[TBL] [Abstract] [Full Text] [Related]
4. PML Nuclear Bodies Are Altered in Adult-Onset Neuronal Intranuclear Hyaline Inclusion Disease.
Nakano Y; Takahashi-Fujigasaki J; Sengoku R; Kanemaru K; Arai T; Kanda T; Murayama S
J Neuropathol Exp Neurol; 2017 Jul; 76(7):585-594. PubMed ID: 28863453
[TBL] [Abstract] [Full Text] [Related]
5. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
Nalluri S; Peirce SK; Tanos R; Abdella HA; Karmali D; Hogarty MD; Goldsmith KC
Cancer Biol Ther; 2015; 16(2):276-86. PubMed ID: 25756510
[TBL] [Abstract] [Full Text] [Related]
6. Nijmegen breakage syndrome (nbs) as a risk factor for CNS involvement in childhood acute lymphoblastic leukemia.
Pastorczak A; Stolarska M; Trelińska J; Zawitkowska J; Kowalczyk J; Mlynarski W;
Pediatr Blood Cancer; 2011 Jul; 57(1):160-2. PubMed ID: 21557461
[TBL] [Abstract] [Full Text] [Related]
7. Impact of cellular senescence signature on ageing research.
Sikora E; Arendt T; Bennett M; Narita M
Ageing Res Rev; 2011 Jan; 10(1):146-52. PubMed ID: 20946972
[TBL] [Abstract] [Full Text] [Related]
8. Useful markers for detecting minimal residual disease in cases of neuroblastoma.
Ootsuka S; Asami S; Sasaki T; Yoshida Y; Nemoto N; Shichino H; Chin M; Mugishima H; Suzuki T
Biol Pharm Bull; 2008 Jun; 31(6):1071-4. PubMed ID: 18520032
[TBL] [Abstract] [Full Text] [Related]
9. Differentiation of Nijmegen breakage syndrome from Fanconi anemia.
Rao VB; Kerketta L; Korgaonkar S; Ghosh K
Genet Mol Res; 2007 Sep; 6(3):622-6. PubMed ID: 18050081
[TBL] [Abstract] [Full Text] [Related]
10. nbs1 variant I171V and breast cancer risk.
Bogdanova N; Schürmann P; Waltes R; Feshchenko S; Zalutsky IV; Bremer M; Dörk T
Breast Cancer Res Treat; 2008 Nov; 112(1):75-9. PubMed ID: 18049891
[TBL] [Abstract] [Full Text] [Related]
11. [Fanconi anemia: genes and function(s) revisited].
Papadopoulo D; Moustacchi E
Med Sci (Paris); 2005; 21(8-9):730-6. PubMed ID: 16115458
[TBL] [Abstract] [Full Text] [Related]
12. A patient with mutations in DNA Ligase IV: clinical features and overlap with Nijmegen breakage syndrome.
Ben-Omran TI; Cerosaletti K; Concannon P; Weitzman S; Nezarati MM
Am J Med Genet A; 2005 Sep; 137A(3):283-7. PubMed ID: 16088910
[TBL] [Abstract] [Full Text] [Related]
13. Significance of survivin mRNA expression in prognosis of neuroblastoma.
Ito R; Asami S; Motohashi S; Ootsuka S; Yamaguchi Y; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
Biol Pharm Bull; 2005 Apr; 28(4):565-8. PubMed ID: 15802787
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical, cytogenetic and molecular characterization of a new case of Nijmegen breakage syndrome in Chile].
Marcelain K; Aracena M; Be C; Navarrete CL; Moreno R; Santos M; Pincheira J
Rev Med Chil; 2004 Feb; 132(2):211-8. PubMed ID: 15449558
[TBL] [Abstract] [Full Text] [Related]
15. T-cell prolymphocytic leukemia with autoimmune manifestations in Nijmegen breakage syndrome.
Michallet AS; Lesca G; Radford-Weiss I; Delarue R; Varet B; Buzyn A
Ann Hematol; 2003 Aug; 82(8):515-517. PubMed ID: 12845481
[TBL] [Abstract] [Full Text] [Related]
16. Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families.
Resnick IB; Kondratenko I; Togoev O; Vasserman N; Shagina I; Evgrafov O; Tverskaya S; Cerosaletti KM; Gatti RA; Concannon P
J Pediatr; 2002 Mar; 140(3):355-61. PubMed ID: 11953735
[TBL] [Abstract] [Full Text] [Related]
17. Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and nbs): experience from the BFM trials.
Seidemann K; Henze G; Beck JD; Sauerbrey A; Kühl J; Mann G; Reiter A
Ann Oncol; 2000; 11 Suppl 1():141-5. PubMed ID: 10707797
[TBL] [Abstract] [Full Text] [Related]
